RXRX
Recursion Pharmaceuticals Inc
Price:  
5.63 
USD
Volume:  
14,457,429.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RXRX WACC - Weighted Average Cost of Capital

The WACC of Recursion Pharmaceuticals Inc (RXRX) is 7.8%.

The Cost of Equity of Recursion Pharmaceuticals Inc (RXRX) is 7.80%.
The Cost of Debt of Recursion Pharmaceuticals Inc (RXRX) is 5.00%.

Range Selected
Cost of equity 6.70% - 8.90% 7.80%
Tax rate 22.10% - 22.30% 22.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.6% - 8.9% 7.8%
WACC

RXRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.61 0.73
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.70% 8.90%
Tax rate 22.10% 22.30%
Debt/Equity ratio 0.01 0.01
Cost of debt 5.00% 5.00%
After-tax WACC 6.6% 8.9%
Selected WACC 7.8%